Cytocom, Inc. is a clinical-stage biopharmaceutical company developing a new class of Immunotherapies targeting cancers, infectious diseases, and autoimmune disorders utilizing a new systems biology approach creating first-in-class or best-in-class therapies. Our therapies may be standalone therapies or may be adjunctive therapies that improve upon the efficacy and safety of standard of care. The Cytocom approach is to deploy ...
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing a new class of Immunotherapies targeting cancers, infectious diseases, and autoimmune disorders utilizing a new systems biology approach creating first-in-class or best-in-class therapies. Our therapies may be standalone therapies or may be adjunctive therapies that improve upon the efficacy and safety of standard of care. The Cytocom approach is to deploy our patented therapies focused on the activation and rebalancing of the body’s immune system.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.